跳至主要内容

ELISA Protocol-Elisa Experiment Standard Operating Method

 The Elisa experiment has been widely used clinically due to its high sensitivity and good specificity. However, each link in the operation has a greater impact on the detection effect of the experiment. If you are not careful, it may lead to incomplete color rendering and patterning. Wait for the result.

ELISA Protocol

The following step by step analysis of the factors that may affect the results of the Elisa test operation.

ELISA protocol

Step 1: Specimen Selection and Preparation

The most commonly used clinical specimens for ELISA determination are serum (plasma), and sometimes specimens such as saliva, cerebrospinal fluid, urine, and feces are also used for specific testing purposes. At present, the clinically used serum samples to determine the markers generally include antigens and antibodies of infectious pathogens, tumor markers, hormones, special proteins, cytokines, and therapeutic drugs. For the collection of serum samples used for hormone and therapeutic drug determination, it is necessary to pay attention to the collection time or even the body position that may affect the determination results. For example, cortisone will have a peak between 4 and 6 in the morning: growth hormone, luteinizing hormone (LH) and follicle stimulating hormone (FSH) are all released in a paroxysmal manner. Therefore, when measuring these hormones , It is necessary to take several blood samples in closely connected time intervals, and use the median value as the measured value. Another example is when changing from a lying position to a standing position, the serum renin activity will increase significantly. Another example is the detection of therapeutic drugs, the best time after taking the drug should be selected according to the pharmacokinetics for blood sampling. The collection of serum specimens used for the detection of antigens and antibodies of infectious pathogens, tumor markers, and special proteins, etc., has no time and position impact, but the following aspects should be considered in the handling and storage:

  1. Pay attention to avoid severe hemolysis. Hemoglobin contains a heme group, which has a peroxide-like activity. Therefore, in the ELISA assay with HRP as the labeling enzyme, if the concentration of hemoglobin in the serum sample is high, it is easy to adsorb during the incubation process. In the solid phase, it reacts with the HRP substrate added later to develop color.
  2. During sample collection and serum separation, attention should be paid to avoid bacterial contamination as much as possible. For the growth of bacteria, some of the secreted enzymes may decompose proteins such as antigens and antibodies; the other is for some bacterial endogenous enzymes such as The β-galactosidase of Escherichia coli itself can cause non-specific interference with the assay method labeled with the corresponding enzyme.
  3. If the serum specimen is separated by aseptic operation, it can be stored at 2~8℃ for one week, if it is for bacteria operation, it is recommended to freeze preservation. The long-term storage of samples should be below -70°C.
  4. For frozen serum specimens, care must be taken to avoid repeated freezing and thawing caused by power outages. The mechanical shearing force produced by repeated freezing and thawing of the specimen will have a destructive effect on the protein and other molecules in the specimen, thereby causing false negative results. In addition, attention should be paid to the mixing of freeze-thaw specimens. Do not vigorously shake, just invert and mix repeatedly.
  5. If the specimens have turbidity or flocculation caused by bacterial contamination during storage, the supernatant should be centrifuged for testing.

Step 2: Preparation of Reagents

In clinical laboratories, generally little attention is paid to the preparation of reagents. The usual practice is to take the reagents out of the refrigerator and use them during the experiment, ignoring that this method may affect the problem of insufficient incubation time later. The consequence of this is false negatives on some weakly positive specimens. Therefore, the most important thing in the preparation of reagents in the ELISA assay is to take the kit out of the refrigerator before starting the experiment and place it at room temperature for 30-60 minutes before performing the measurement, so that the kit is at room temperature before use. balance. The purpose of this is mainly to enable the temperature in the reaction micropores to reach the required height quickly in the subsequent incubation reaction step to meet the measurement requirements.

Step 3: Add Sample

  1. The specimen is serum: it is best to store the blood naturally for 1-2 hours, and then centrifuge at 3000 rpm for 15 minutes; the specimen is plasma: a blood specimen collection tube containing anticoagulant must be used, and the blood collection tube must be inverted immediately after blood collection Mix for 5-10 times. After standing for a period of time, centrifuge at 3000 rpm for 15 minutes; if it is tested within a few days, it can be placed in a refrigerator at 2-8°C, and if it is to be stored, it should be placed in a low-temperature refrigerator at -20°C.
  2. Put the sample into the incubator in time after adding the sample.
  3. After adding the enzyme reagent, wipe the surface of the microtiter plate with absorbent paper to dry.
  4. If AT or other automatic sample addition is used, it is best to choose FAME or other post-processing instruments to add enzyme reagents.
  5. When there are many specimens, please operate in batches.
  6. The addition of serum samples is almost the only step to add samples using a micropipette. The key points that must be paid attention to when using the micropipette to add samples are: do not add the sample too fast, avoid adding to the upper part of the hole wall, and do not splash or generate bubbles. The sample addition is too fast, and the accuracy and uniformity of the micro sample addition cannot be guaranteed. The non-coated area added to the upper part of the hole wall can easily lead to non-specific adsorption. Spills can contaminate adjacent holes. When bubbles appear, the interface of the reaction liquid is different.

Step 4: Incubate

  1. Incubation is the most critical factor affecting the success or failure of the ELISA assay. ELISA is a solid-phase immunoassay. The antigen-antibody binding reaction is carried out on the solid phase. To make the antigen or antibody in the liquid phase completely bind to the specific antibody or antigen on the solid phase, it must be reacted under certain temperature conditions. time. The time required for incubation is inversely proportional to the temperature, that is, the higher the temperature, the shorter the time required. The most commonly used incubation temperatures are 37°C and room temperature, followed by 43°C and 2-8°C. Strictly control the incubation time according to the operating instructions;
  2. Attach a cover or cover during incubation to prevent the specimen or diluent from evaporating and adsorbing on the wall of the hole.

Step 5: Wash the Board

Make sure that the lotion fills the holes and the washing needle is unblocked. After washing the plate, it is best to gently pat dry on absorbent paper (choose a clean, no or less dusty absorbent material); when there are too many reaction plates, arrange them reasonably, or use more Several plate washer to avoid long waiting time.

Step 6: Color Development

The color developer should be prepared before use as far as possible, and the expired color developer should not be used. The light blue TMB color developer is not used; when adding samples, the color developer should not flow out.

Step 7: Termination

Avoid generating bubbles when adding stop solution, which may lead to false positive results.

Step 8: Read the Board

During the entire operation, ensure that the ELISA plate does not touch hypochlorous acid; realize the automation of ELISA testing standards as much as possible, and effectively improve the quality of testing.

In actual operation, in addition to selecting high-quality reagents, you must strictly follow the operating steps, and at the same time perform indoor quality control and inter-room quality evaluation, and test each specimen with a rigorous work style to ensure the quality of the test.

Contact Us:

Email : marketing@medicilon.com

Tel : +44 1223 981 792 (Europe)

+82 (0)70-8269-5849 (South Korea)

08044216898 (Japan)

+86 021 58591500 (China)

Website: https://www.medicilon.com

评论

此博客中的热门博文

What is preclinical testing?

In the process of  preclinical testing  of a compound or biological agent into a drug, the compound involved must go through the testing phase. First, we need to identify potential targets that can treat the disease. Then, a variety of compounds or preparations are screened out. Any compound that has shown potential as a drug for the treatment of this disease needs to be tested for toxicity before clinical testing to reduce the possibility of injury. preclinical testing What is the basis of preclinical testing? According to US Food and Drug Administration (FDA) regulations, a series of tests are required before a new drug is approved for use. In the first stage, basic research determines a hypothetical target for the treatment of a certain disease, and then screens small molecules or biological compounds to discover any substance with the potential to treat the disease. Then, a  preclinical research  phase followed, before which, as described above, the potential toxicity of the compou

Inventory of the three major in vitro pharmacokinetic research methods

  The metabolic properties of a compound are an essential factor in whether or not it can be used as a drug in the clinical setting, so pharmacokinetic studies of newly synthesized compounds are required in drug development. In vitro incubation with liver microsomes, recombinant CYP450 enzyme lines, and in vitro incubation with hepatocytes are some of the more common in vitro drug metabolism methods. 1. In vitro incubation method with liver microsomes The metabolic stability and metabolic phenotypes of candidate compounds in different species of liver microsomes are good predictors of the metabolic properties of compounds in vivo. They are practical tools for evaluating candidate compounds in the pre-development phase of drug development. Liver microsomes include rat liver microsomes, human liver microsomes, canine liver microsomes, monkey liver microsomes, and mouse liver microsomes. In in vitro incubation of the liver, microsomes are the "gold standard" for in vitro d

Enzyme Activity Assay Service

  Enzymatic assay Lance Assay Alphascreen Assay Z’-LYTE Assay Adapta Assay Kinase-Glo Assay ADP-Glo Assay Ligand Binding Assay ELISA Assay HTRF Assay Enzyme activity assays  are laboratory methods for measuring enzymatic activity. They are vital for the study of enzyme kinetics and enzyme inhibition. Enzyme units : Amounts of enzymes can either be expressed as molar amounts, as with any other chemical, or measured in terms of activity, in enzyme units. Medicilon provides various  enzyme activity assays  for  kinases , phosphatases, proteinases, deacetylase, peptidase, esterase, and other enzymes. Our line of well-characterized immunoassays and biochemical kits ensures accurate and reproducible results. Enzyme is a  large category of bio-molecules  that catalyze various biological processes including metabolic processes, cellular signaling and regulation, cell division and apoptosis. Enzymatic reactions convert substrate molecules into chemically modified molecules products with high sp